Vaccine, Von der Leyen: tomorrow contract with CureVac for 405 million doses

• Coronavirus, Ema begins Modern vaccine approval process.

  The company: "94.5% effective"

• Covid changes up to 100 times less than HIV, an easier vaccine

• Covid-19, the creator of the Pfizer-BioNtech vaccine: normality only from next winter

• Vaccine, third experimentation of a Janssen preparation is underway

Share

November 16, 2020 After the new contract - the fifth signed by the EU - for the supply of vaccines by

"a sixth agreement with

will soon follow

, with which we have concluded exploratory negotiations and we hope to finalize the contract as soon as possible. ".

said in a short video posted on Twitter

.

We continue to work to secure safe & effective vaccines to end the pandemic.

I am glad to announce a new agreement to buy up to 405 million doses of a vaccine produced by the European company @CureVacRNAhttps: //t.co/H1gFQH7FAX

- Ursula von der Leyen (@vonderleyen) November 16, 2020

"I am happy to announce that tomorrow we will authorize a new contract to secure another Covid-19 vaccine for Europeans" and "this contract will allow us to buy up to 405 million doses. of the vaccine produced by the European company CureVac ", he specified.

"The coronavirus continues to spread rapidly in Europe and we need a safe vaccine," said the Commission president.

"We still don't know which will be the safest and most effective, but in any case the European Medicines Agency will only authorize it after a robust evaluation," said the president of the EU Commission.

"We gave funds to CureVac a few months ago, together with the Bei - remembers von der Leyen - we did it to support the progress on this vaccine, which is now tangible. If the vaccine proves effective and safe, every member state will receive it. at the same time, on a proportional basis to the population and under the same conditions. It is the fifth contract with a pharmaceutical company for our portfolio of vaccines against Covid-19 ".